Brust-zentrum
Brust-zentrum, operating as Affidea brustCare, is a Swiss specialized breast cancer diagnosis and treatment provider operating two centers in Zürich and Tessin, delivering multidisciplinary care from screening to reconstruction via Swiss health insurance reimbursement.
- Company typePrivate
- Founded2002
- HeadquartersZürich, Switzerland
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Brust-zentrum does
Brust-zentrum operates in the market as Affidea brustCare, a specialized breast cancer diagnosis and treatment provider in Switzerland. The legal entity emerged from the combination of Brust-Zentrum Zürich and Plastic Surgery Group and is positioned as the first provider of truly specialized breast cancer care in Switzerland; the company now operates under the Affidea healthcare group as its strategic parent.
The organization runs two physical breast centers serving the German-speaking region (Brust-Zentrum Zürich) and the Italian-speaking region (Affidea brustCare Tessin). Its underlying clinical technology is a multidisciplinary care model that integrates gynecologists, oncologists, radiologists, breast and plastic surgeons, oncology nurses, genetic counselors, and psycho-oncologists, supported by a tumor board for case coordination and an active clinical studies program that has enrolled over 1,000 study patients since 2007. The technology stack is primarily clinical rather than software-based: the digital layer consists of a multilingual website (DE/IT/EN), an online breast cancer self-check tool, a podcast series, and contact/appointment forms. Core offerings span the full patient journey — prevention/early detection, mammography, biopsy, surgery, reconstruction, chemotherapy, radiation, immunotherapy, targeted therapy, anti-hormonal therapy, supportive and complementary medicine, genetic counseling, and expert second opinions. Disclosed quality signals include more than 10,000 primary breast cancer operations performed and a 3% reoperation rate, alongside HI Label (ECC) and DKG Brust plus Senologie certifications.
The business model is fee-for-service healthcare delivery reimbursed through Swiss mandatory health insurance (KVG/HIV) and supplementary insurance; pricing is not publicly disclosed and is determined per treatment plan. Go-to-market relies on an Ärztenetzwerk (referring physician network) for bottom-of-funnel acquisition, a multilingual website and online self-check tool for top-of-funnel demand capture, and direct contact forms for self-serve appointment requests. Customer segments are individual breast cancer patients (primary) and referring physicians (secondary enabler), with no enterprise or B2B contracting layer.
Brust-zentrum firmographics
Firmographics- Name
- Brust-zentrum
- Legal name
- Affidea brustCare
- Website
- https://brust-zentrum.ch
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Brust-zentrum, operating as Affidea brustCare, is a Swiss specialized breast cancer diagnosis and treatment provider operating two centers in Zürich and Tessin, delivering multidisciplinary care from screening to reconstruction via Swiss health insurance reimbursement.
- Ownership category
- akta.pro rank
Brust-zentrum industry classification
Industry- Product category
- Specialty Oncology / Breast Cancer Care Services
- NAICS
- Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Breast Oncology (HLAKAFAJ)
- akta.pro secondary industries
- Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD), Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC)
Keywords
Where Brust-zentrum is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
Brust-zentrum business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Medical Services Revenue: Fee-for-service healthcare delivery model providing breast cancer screening, diagnosis, and treatment services reimbursed through Swiss health insurance (KVG/HIV) and supplementary insurance. Services include mammography, biopsies, surgeries, chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormonal therapy, breast reconstruction, and supportive care.
- Second Opinion Consultations: Expert second opinion services for breast cancer diagnosis and treatment planning, offered as a specialized consultation service.
- Genetic Counseling Services: Genetic risk assessment and counseling for hereditary breast cancer predisposition.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Brust-zentrum product offering
Product offeringCore offering
Brust-zentrum (Affidea brustCare) operates two specialized breast cancer centers in Zürich and Tessin (Switzerland) delivering the complete patient journey from prevention and early detection through diagnosis, multimodal treatment, reconstruction, and aftercare. Core services include mammography, breast biopsy, breast cancer surgery, breast reconstruction, chemotherapy, radiation therapy, immunotherapy, targeted therapy, anti-hormone therapy, genetic counseling, second opinions, tumor board multidisciplinary review, and clinical trial enrollment.
Product overview
Affidea brustCare is a specialized breast cancer treatment center network in Switzerland, operating at two locations (Zürich and Tessin). The organization offers a comprehensive, integrated range of breast cancer care services spanning the entire patient journey: from early detection and prevention (Früherkennung), through diagnostic services including mammography and biopsy, to full treatment spectrum including surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and anti-hormone therapy. The center also provides supportive care, complementary and integrative medicine, genetic counseling, expert second opinions, and access to clinical trials. The organization emerged from the merger of Brust-Zentrum Zürich and Plastic Surgery Group, combining surgical expertise with oncological care in a multi-disciplinary team approach.
Differentiator
Problem solved
Functional benefit
Products and services
- Mammografie (Mammography) Mammography screening and diagnostic imaging service for breast cancer detection and assessment, available to patients across the two breast centers in Switzerland.
- Brustbiopsie (Breast Biopsy) Tissue sampling and pathological examination service used to confirm or rule out breast cancer following suspicious imaging or clinical findings.
- Brustkrebsoperation (Breast Cancer Surgery) Surgical intervention for breast cancer, performed by breast and plastic surgeons as part of the multidisciplinary treatment pathway.
- Brustrekonstruktion (Breast Reconstruction) Breast reconstruction surgery performed by plastic surgeons following mastectomy or as part of breast cancer surgical treatment.
- Chemotherapie (Chemotherapy) Chemotherapy treatment delivered to breast cancer patients as part of systemic therapy coordinated by the oncology team.
- Strahlentherapie (Radiation Therapy) Radiation therapy treatment for breast cancer, coordinated within the multidisciplinary breast cancer care pathway.
- Immuntherapie (Immunotherapy) Immunotherapy treatment offered to breast cancer patients as part of modern systemic therapy options.
- Zielgerichtete Therapie (Targeted Therapy) Targeted therapy treatment tailored to the molecular profile of the patient's breast cancer.
- Antihormontherapie (Anti-Hormone Therapy) Anti-hormone therapy treatment for hormone receptor-positive breast cancer, managed by the oncology team.
- Medikamentöse Therapie (Pharmacological Therapy) Pharmacological drug therapy provided to breast cancer patients as part of their individualized treatment plan.
- Zweitmeinung (Second Opinion) Expert second opinion consultation service for patients seeking confirmation or alternative options for breast cancer diagnosis or treatment recommendations.
- Früherkennung (Early Detection) Breast cancer early detection and prevention screening service for asymptomatic and at-risk patients.
- Genetische Beratung (Genetic Counseling) Genetic risk assessment and counseling service for patients with a family history or concern about hereditary breast cancer predisposition.
- Klinische Studien (Clinical Trials) Clinical trial program providing breast cancer patients with access to innovative and evidence-based treatment approaches.
- Tumorboard Anmeldung (Tumor Board Registration) Tumor board case review and registration service providing multidisciplinary specialist discussion for breast cancer diagnosis and treatment planning.
- Brustkrebs Online Check (Online Breast Cancer Check) Online self-assessment tool enabling patients to evaluate breast cancer symptoms and risk factors digitally before requesting an appointment.
Quantifiable outcome
- 3% reoperation rate demonstrating high surgical precision and quality outcomes
- +2 more outcomes
Companies that use Brust-zentrum
Customer profileSegments2 records
Ideal customer profiles2 records
Brust-zentrum technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Brust-zentrum partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Ärztenetzwerk (Physician Network)coreCollaborative network of referring physicians and medical specialists across Switzerland, facilitating patient referrals and coordinated multidisciplinary care for breast cancer patients.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Brust-zentrum competitors and assessment
Company assessmentBroad incumbents
- Asklepios Kliniken: Large German hospital group with multiple sites offering breast surgery, oncology, and reconstructive services; comparable as a broad incumbent operator with adjacent specialty breast services but not exclusively focused on breast oncology.
- Helios Kliniken: One of Europe's largest private hospital groups operating many sites across Germany with breast surgery and oncology offerings; comparable as a broad incumbent providing overlapping breast services at scale but as part of a wider multi-specialty portfolio.
- Sana Kliniken: German private hospital group operating numerous facilities with breast surgery, oncology, and reconstructive offerings; comparable as a broad incumbent providing overlapping breast services within a multi-specialty hospital network.
Direct peers
- European Institute of Oncology (IEO): Milan-based specialist cancer hospital focused exclusively on oncology, including a dedicated breast cancer program with multidisciplinary care and clinical research; comparable as a European specialized oncology center model.
- Centre du Sein HUG (Hôpitaux Universitaires de Genève): University hospital breast center in Geneva providing multidisciplinary breast cancer screening, diagnosis, and treatment; comparable as a Romandie-based specialist competitor offering a similar integrated breast care pathway.
- Brustzentrum Universitätsklinikum München (LMU): University hospital breast center in Munich offering multidisciplinary breast cancer diagnosis, treatment, and clinical trials; comparable as a European university-affiliated specialist breast center with a similar multidisciplinary model.
- Inselspital Bern Breast Center: University hospital breast center in Bern covering central Switzerland with multidisciplinary oncology, surgery, and reconstructive services; comparable as another Swiss university-affiliated specialist breast care provider.
- Hirslanden Klinik: Largest private hospital group in Switzerland with dedicated breast surgery and oncology offerings across multiple cantons; comparable as a private-pay specialist competitor combining surgical, reconstructive, and oncologic breast services in the Swiss market.
- Brustzentrum Charité Berlin: Large German university hospital breast center at Charité with multidisciplinary breast oncology, surgery, reconstruction, and clinical trials; comparable as a leading European specialist breast center with similar certifications (DKG) and academic standing.
- Universitätsspital Zürich (USZ) Breast Center: University hospital in Zürich offering a dedicated breast center with multidisciplinary oncology services; directly comparable as a local specialist competitor serving the same catchment area with overlapping surgical, medical oncology, and imaging capabilities.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Brust-zentrum social profiles
Digital presenceBrust-zentrum compliance and trust
Trust signalCompliance2 records
Brust-zentrum financial estimates
Financial estimateRevenue estimate
Valuation estimate
Brust-zentrum leadership team
Management profileNumber of profiles
Brust-zentrum funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Brust-zentrum M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Brust-zentrum
What does Brust-zentrum do?
Brust-zentrum (Affidea brustCare) operates two specialized breast cancer centers in Zürich and Tessin (Switzerland) delivering the complete patient journey from prevention and early detection through diagnosis, multimodal treatment, reconstruction, and aftercare. Core services include mammography, breast biopsy, breast cancer surgery, breast reconstruction, chemotherapy, radiation therapy, immunotherapy, targeted therapy, anti-hormone therapy, genetic counseling, second opinions, tumor board multidisciplinary review, and clinical trial enrollment.
Is Brust-zentrum a public or private company?
Brust-zentrum is a private company. It is classified as corporate owned and is currently operating.
When was Brust-zentrum founded?
Brust-zentrum was founded in 2002. It employs 51 to 100 people.
Where is Brust-zentrum based?
Brust-zentrum is headquartered in Zürich, Switzerland, in the Europe region.
How does Brust-zentrum make money?
Three revenue lines are on record. Medical Services Revenue is the primary driver. The others are second Opinion Consultations and genetic Counseling Services.
Who are Brust-zentrum's main competitors?
Broad incumbents on record are Asklepios Kliniken, Helios Kliniken and Sana Kliniken. Direct peers are European Institute of Oncology (IEO), Centre du Sein HUG (Hôpitaux Universitaires de Genève), Brustzentrum Universitätsklinikum München (LMU), Inselspital Bern Breast Center, Hirslanden Klinik, Brustzentrum Charité Berlin and Universitätsspital Zürich (USZ) Breast Center.
Does Brust-zentrum have an API?
No public API is recorded for Brust-zentrum.
What industry is Brust-zentrum in?
Brust-zentrum's product category is Specialty Oncology / Breast Cancer Care Services. Its primary akta.pro industry code is HLAKAFAJ, Breast Oncology, with a secondary code of HLAFAKAD, Breast Imaging Centers (Mammography/Tomosynthesis). Its NAICS code is 621512 and its SIC code is 8011.